Login / Signup

Rapid review showed that real-world results on how nirsevimab prevented respiratory syncytial virus hospitalisations were similar to randomised trials.

Ilari KuitunenMarjo Renko
Published in: Acta paediatrica (Oslo, Norway : 1992) (2024)
Keyphrases
  • respiratory syncytial virus
  • clinical trial
  • open label
  • double blind
  • study protocol
  • placebo controlled
  • randomized controlled trial